RSS   Newsletter   Contact   Advertise with us
Post Online Media

Agios Pharmaceuticals appoints Jacqualyn Fouse to board

Jacqualyn FouseDecember 6, 2017, Cambridge, Mass., USA - Agios Pharmaceuticals, a pharmaceutical company, announced the appointment of Jacqualyn Fouse to its board of directors.
Dr. Fouse previously served as president and chief operating officer of Celgene Corporation until April 2017, and as a member of Celgene's board of directors through June 2017.

Dr. Fouse joined Celgene in 2010 as chief financial officer and was named president of the company's global hematology & oncology franchise in 2014.

Before joining Celgene, she served as chief financial officer of Bunge Limited.

Prior to Bunge, Dr. Fouse served as senior vice president, chief financial officer, and head of corporate strategy at Alcon Laboratoriesy.

Prior to her tenure with Alcon, she held a variety of senior leadership roles with international companies, spending almost a decade of her career in Switzerland.

Dr. Fouse earned her B.A. and M.A. in economics and a Ph.D. in finance from the University of Texas at Arlington.


 LATEST MOVES FROM Massachusetts 


POST Online Media does not use cookies to collect information about visitors.   OK, hide this message   Third party ads may be using cookies, you can see how here.